Haemonetics Corp. (HAE) Misses Q2 EPS Views; Affirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $119.79 +1.24%
Revenue Growth %: +5.6%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
PFBX, GOVB, VABK, More
Revenue Growth %: +5.6%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.65, $0.13 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $170.4 million.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Gouverneur Bancorp, Inc. (GOVB) Tops Q4 EPS by 23c
- Chain Bridge Bancorp, Inc. (CBNA) Tops Q3 EPS by 166c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
